Blockade of Caspases Inhibits Amebic Liver Abscess Formation in a Mouse Model of Disease
AUTOR(ES)
Yan, Le
FONTE
American Society for Microbiology
RESUMO
We looked at the effect of inhibiting caspases on amebic liver abscess in the mouse model of infection. A dose of the pan-caspase inhibitor benzyloxycarbonyl-V-A-D-O-methyl fluoromethyl ketone (Z-VAD-FMK; R & D Systems) given to SCID mice 2 h prior to direct hepatic inoculation with Entamoeba histolytica trophozoites, and 12 h after amebic inoculation, reduced the mean liver abscess size by 70% at 24 h compared to a control group. These data indicate that apoptosis plays a significant but not an exclusive role in amebic liver abscess formation in the mouse model.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=98890Documentos Relacionados
- Innate Immunity to Amebic Liver Abscess Is Dependent on Gamma Interferon and Nitric Oxide in a Murine Model of Disease
- Diagnosis and management of amebic liver abscess in children.
- Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice.
- Liver Abscess Production by Non-Spore-Forming Anaerobic Bacteria in a Mouse Model
- Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.